Literature DB >> 25644062

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms.

N Désiré1,2, Y Ngo3,4, J-F Franetich2,5, L Dembele2,5, D Mazier2,5, J-C Vaillant6, T Poynard3,4, V Thibault1,2.   

Abstract

Hepatitis B (HBV) virus infection is characterized by the overproduction of subviral particles (SVP) over infectious Dane particles (VP). Precise regulation of the ratio between these forms is unknown, but its fluctuation may have a clinical impact. An enrichment method was applied to assess the SVP/VP ratio in chronically infected patients (CHB) and to compare the sensitivity of HBs antigen (HBsAg) and DNA detection methods. Plasmas from 9 genotype A-D CHB patients were fractionated on Nycodenz(®) gradients, and both HBV DNA and HBsAg were quantified in each collected fraction using standardized techniques expressed in IU/mL. Infection of primary human hepatocytes (PHHs) was performed with crude or fractionated plasma. Independently of the genotype, all plasmas showed a similar rate-zonal separation profile characterized by a bottom DNA-enriched peak surmounted by HBsAg-enriched fractions. Inoculation of PHH with plasma-derived VP-enriched fractions led to long-lasting production of virus in cell supernatants with a SVP/VP ratio similar to that observed in patient plasmas. In the VP fraction, one IU of HBsAg corresponded to approximately 5 million IU of HBV DNA. Rate-zonal gradient separation directly applied on patient plasma allows a better insight into the distribution of VP in HBeAg-positive CHB carriers. This study highlights the sensitivity difference of the techniques classically used to monitor HBV infection and indicates that VP-associated HBsAg contributes modestly to the overall amount of total circulating HBsAg in CHB. Such a fractionation approach should help to understand the fine regulation of HBsAg production over replication at different stages of CHB.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  disease stage; genotype; in vitro replication; primary human hepatocyte; rate-zonal separation

Mesh:

Substances:

Year:  2015        PMID: 25644062     DOI: 10.1111/jvh.12387

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  4 in total

1.  Contribution of quantitative viral markers to document hepatitis B virus compartmentalization in cerebrospinal fluid during hepatitis B with neuropathies.

Authors:  Charlotte Pronier; Dominique Guyader; Caroline Jézequel; Pierre Tattevin; Vincent Thibault
Journal:  J Neurovirol       Date:  2018-08-10       Impact factor: 2.643

2.  Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.

Authors:  Simon B Larsson; Sebastian Malmström; Charles Hannoun; Gunnar Norkrans; Magnus Lindh
Journal:  Virol J       Date:  2015-12-09       Impact factor: 4.099

3.  High serum levels of pregenomic RNA reflect frequently failing reverse transcription in hepatitis B virus particles.

Authors:  Kasthuri Prakash; Gustaf E Rydell; Simon B Larsson; Maria Andersson; Gunnar Norkrans; Heléne Norder; Magnus Lindh
Journal:  Virol J       Date:  2018-05-15       Impact factor: 4.099

Review 4.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.